InterventionsHuman trial

Efficacy and Safety of VCT220 in Chinese Adults with Overweight or Obesity

ADA Scientific Sessions 2025 Abstract

The paper

Linong Ji, Leili Gao, Chao Meng,

Xianghua Zhang, Juan Huang,

Beijing

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Poster 743-P

doi.org/10.2337/db25-743-p

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026